|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
ACT 101 Human Safety in Clinical Research
Pharmaceutical companies must pay close attention to the safety of human subjects at every stage of drug development, as explained in this QA view of the policies and regulations that make the system work.
Advertisement
Articles in this issue
almost 25 years ago
Letters to the Editoralmost 25 years ago
Conference Reportsalmost 25 years ago
Affairs of Statealmost 25 years ago
Pen-Based Computingalmost 25 years ago
Some Do--Some Watch Over Those Who Doalmost 25 years ago
Communication Skills for Monitors—A Vital Training OpportunityAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
2
ACT Brief: Real-Time Data Harmonization Infrastructure, Modern Trial Payments, and SCLC Drug Confirmatory Failure
3
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
4
Tapping the Global Potential of China’s Biotech Surge
5